# Autodesk, Inc.: financial statements, quarterly

ADSK · Nasdaq · CIK 769397 · [Technology](/sectors/technology.md) · fiscal year ends Jan 31

Pages: [Overview](/companies/adsk.md) · [Financials](/companies/adsk/financials.md) · [Filings](/companies/adsk/filings.md) · [Insiders](/companies/adsk/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/adsk/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2024 (2023-10-31) | Q4 FY2024 (2024-01-31) | Q1 FY2025 (2024-04-30) | Q2 FY2025 (2024-07-31) | Q3 FY2025 (2024-10-31) | Q4 FY2025 (2025-01-31) | Q1 FY2026 (2025-04-30) | Q2 FY2026 (2025-07-31) | Q3 FY2026 (2025-10-31) | Q4 FY2026 (2026-01-31) | Q1 FY2027 (2026-04-30) | Q2 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,414](/filings/0000769397-24-000181.md) | [1,469 d](/filings/0000769397-26-000015.md) | [1,417](/filings/0000769397-25-000071.md) | [1,505](/filings/0000769397-25-000117.md) | [1,570](/filings/0000769397-25-000129.md) | [1,639 d](/filings/0000769397-26-000015.md) | [1,633](/filings/0000769397-26-000044.md) | [1,763](/filings/0000769397-26-000061.md) | [1,853](/filings/0000769397-25-000129.md) | [1,957 d](/filings/0000769397-26-000015.md) | [1,934](/filings/0000769397-26-000044.md) | [2,046](/filings/0000769397-26-000061.md) |
| Cost of revenue | $m | [127](/filings/0000769397-24-000181.md) | [130 d](/filings/0000769397-26-000015.md) | [137](/filings/0000769397-25-000071.md) | [140](/filings/0000769397-25-000117.md) | [147](/filings/0000769397-25-000129.md) | [154 d](/filings/0000769397-26-000015.md) | [160](/filings/0000769397-26-000044.md) | [159](/filings/0000769397-26-000061.md) | [165](/filings/0000769397-25-000129.md) | [166 d](/filings/0000769397-26-000015.md) | [175](/filings/0000769397-26-000044.md) | [176](/filings/0000769397-26-000061.md) |
| Gross profit | $m | [1,287](/filings/0000769397-24-000181.md) | [1,339 d](/filings/0000769397-26-000015.md) | [1,280](/filings/0000769397-25-000071.md) | [1,365](/filings/0000769397-25-000117.md) | [1,423](/filings/0000769397-25-000129.md) | [1,485 d](/filings/0000769397-26-000015.md) | [1,473](/filings/0000769397-26-000044.md) | [1,604](/filings/0000769397-26-000061.md) | [1,688](/filings/0000769397-25-000129.md) | [1,791 d](/filings/0000769397-26-000015.md) | [1,759](/filings/0000769397-26-000044.md) | [1,870](/filings/0000769397-26-000061.md) |
| Research and development | $m | [339](/filings/0000769397-24-000181.md) | [352 d](/filings/0000769397-26-000015.md) | [346](/filings/0000769397-25-000071.md) | [368](/filings/0000769397-25-000117.md) | [378](/filings/0000769397-25-000129.md) | [393 d](/filings/0000769397-26-000015.md) | [394](/filings/0000769397-26-000044.md) | [413](/filings/0000769397-26-000061.md) | [416](/filings/0000769397-25-000129.md) | [420 d](/filings/0000769397-26-000015.md) | [421](/filings/0000769397-26-000044.md) | [464](/filings/0000769397-26-000061.md) |
| Operating income | $m | [334](/filings/0000769397-24-000181.md) | [315 d](/filings/0000769397-26-000015.md) | [299](/filings/0000769397-25-000071.md) | [343](/filings/0000769397-25-000117.md) | [346](/filings/0000769397-25-000129.md) | [366 d](/filings/0000769397-26-000015.md) | [233](/filings/0000769397-26-000044.md) | [444](/filings/0000769397-26-000061.md) | [470](/filings/0000769397-25-000129.md) | [431 d](/filings/0000769397-26-000015.md) | [541](/filings/0000769397-26-000044.md) | [599](/filings/0000769397-26-000061.md) |
| Interest expense | $m | not reported | not reported | [18.0](/filings/0000769397-25-000071.md) | [18.0](/filings/0000769397-25-000117.md) | [18.0](/filings/0000769397-25-000129.md) | [17.0 d](/filings/0000769397-26-000015.md) | [18.0](/filings/0000769397-26-000044.md) | [19.0](/filings/0000769397-25-000117.md) | [22.0](/filings/0000769397-25-000129.md) | [21.0 d](/filings/0000769397-26-000015.md) | [21.0](/filings/0000769397-26-000044.md) | not reported |
| Income tax | $m | [79.0](/filings/0000769397-24-000181.md) | [55.0 d](/filings/0000769397-26-000015.md) | [57.0](/filings/0000769397-25-000071.md) | [70.0](/filings/0000769397-25-000117.md) | [76.0](/filings/0000769397-25-000129.md) | [69.0 d](/filings/0000769397-26-000015.md) | [82.0](/filings/0000769397-26-000044.md) | [143](/filings/0000769397-26-000061.md) | [125](/filings/0000769397-25-000129.md) | [129 d](/filings/0000769397-26-000015.md) | [108](/filings/0000769397-26-000044.md) | [101](/filings/0000769397-26-000061.md) |
| Net income | $m | [241](/filings/0000769397-24-000181.md) | [282 d](/filings/0000769397-26-000015.md) | [252](/filings/0000769397-25-000129.md) | [282](/filings/0000769397-25-000129.md) | [275](/filings/0000769397-25-000129.md) | [303 d](/filings/0000769397-26-000015.md) | [152](/filings/0000769397-26-000061.md) | [313](/filings/0000769397-26-000061.md) | [343](/filings/0000769397-25-000129.md) | [316 d](/filings/0000769397-26-000015.md) | [491](/filings/0000769397-26-000061.md) | [492](/filings/0000769397-26-000061.md) |
| Diluted EPS | $ per share | [1.12](/filings/0000769397-24-000181.md) | not reported | [1.16](/filings/0000769397-25-000071.md) | [1.30](/filings/0000769397-25-000117.md) | [1.27](/filings/0000769397-25-000129.md) | not reported | [0.70](/filings/0000769397-26-000044.md) | [1.46](/filings/0000769397-26-000061.md) | [1.60](/filings/0000769397-25-000129.md) | not reported | [2.32](/filings/0000769397-26-000044.md) | [2.33](/filings/0000769397-26-000061.md) |
| Basic EPS | $ per share | [1.13](/filings/0000769397-24-000181.md) | not reported | [1.17](/filings/0000769397-25-000071.md) | [1.31](/filings/0000769397-25-000117.md) | [1.28](/filings/0000769397-25-000129.md) | not reported | [0.71](/filings/0000769397-26-000044.md) | [1.47](/filings/0000769397-26-000061.md) | [1.61](/filings/0000769397-25-000129.md) | not reported | [2.33](/filings/0000769397-26-000044.md) | [2.34](/filings/0000769397-26-000061.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2024 (2023-10-31) | FY2024 (2024-01-31) | Q1 FY2025 (2024-04-30) | Q2 FY2025 (2024-07-31) | Q3 FY2025 (2024-10-31) | FY2025 (2025-01-31) | Q1 FY2026 (2025-04-30) | Q2 FY2026 (2025-07-31) | Q3 FY2026 (2025-10-31) | FY2026 (2026-01-31) | Q1 FY2027 (2026-04-30) | Q2 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [1.5](/filings/0000769397-23-000193.md) | [1.9](/filings/0000769397-25-000019.md) | [1.7](/filings/0000769397-24-000091.md) | [1.5](/filings/0000769397-24-000150.md) | [1.4](/filings/0000769397-24-000181.md) | [1.6](/filings/0000769397-26-000015.md) | [1.8](/filings/0000769397-25-000071.md) | [2.0](/filings/0000769397-25-000117.md) | [2.0](/filings/0000769397-25-000129.md) | [2.2](/filings/0000769397-26-000061.md) | [2.7](/filings/0000769397-26-000044.md) | [4.1](/filings/0000769397-26-000061.md) |
| Current assets | $bn | [2.9](/filings/0000769397-23-000193.md) | [3.6](/filings/0000769397-25-000019.md) | [2.8](/filings/0000769397-24-000091.md) | [2.8](/filings/0000769397-24-000150.md) | [2.9](/filings/0000769397-24-000181.md) | [3.5](/filings/0000769397-26-000015.md) | [3.2](/filings/0000769397-25-000071.md) | [3.5](/filings/0000769397-25-000117.md) | [3.9](/filings/0000769397-25-000129.md) | [4.9](/filings/0000769397-26-000061.md) | [4.4](/filings/0000769397-26-000044.md) | [5.7](/filings/0000769397-26-000061.md) |
| Total assets | $bn | [9.2](/filings/0000769397-23-000193.md) | [9.9](/filings/0000769397-25-000019.md) | [9.8](/filings/0000769397-24-000091.md) | [10.0](/filings/0000769397-24-000150.md) | [10.1](/filings/0000769397-24-000181.md) | [10.8](/filings/0000769397-26-000015.md) | [10.6](/filings/0000769397-25-000071.md) | [10.9](/filings/0000769397-25-000117.md) | [11.2](/filings/0000769397-25-000129.md) | [12.5](/filings/0000769397-26-000061.md) | [11.9](/filings/0000769397-26-000044.md) | [13.0](/filings/0000769397-26-000061.md) |
| Current liabilities | $bn | [3.9](/filings/0000769397-23-000193.md) | [4.4](/filings/0000769397-25-000019.md) | [4.1](/filings/0000769397-24-000091.md) | [4.3](/filings/0000769397-24-000150.md) | [4.5](/filings/0000769397-24-000181.md) | [5.2](/filings/0000769397-26-000015.md) | [4.9](/filings/0000769397-25-000071.md) | [4.6](/filings/0000769397-25-000117.md) | [4.7](/filings/0000769397-25-000129.md) | [5.8](/filings/0000769397-26-000061.md) | [5.2](/filings/0000769397-26-000044.md) | [6.6](/filings/0000769397-26-000061.md) |
| Long-term debt | $bn | [2.3](/filings/0000769397-23-000193.md) | [2.3](/filings/0000769397-24-000090.md) | [2.3](/filings/0000769397-24-000091.md) | [2.3](/filings/0000769397-24-000150.md) | [2.3](/filings/0000769397-24-000181.md) | [2.3](/filings/0000769397-25-000019.md) | [2.3](/filings/0000769397-25-000071.md) | [2.5](/filings/0000769397-25-000117.md) | [2.5](/filings/0000769397-25-000129.md) | [2.5](/filings/0000769397-26-000015.md) | [2.5](/filings/0000769397-26-000044.md) | [2.5](/filings/0000769397-26-000061.md) |
| Short-term borrowings | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0000769397-26-000061.md) | not reported | [1.0](/filings/0000769397-26-000061.md) |
| Shareholders' equity | $bn | [1.5](/filings/0000769397-24-000181.md) | [1.9](/filings/0000769397-26-000015.md) | [2.2](/filings/0000769397-25-000129.md) | [2.5](/filings/0000769397-25-000129.md) | [2.6](/filings/0000769397-25-000129.md) | [2.6](/filings/0000769397-26-000061.md) | [2.6](/filings/0000769397-26-000061.md) | [2.7](/filings/0000769397-26-000061.md) | [2.9](/filings/0000769397-25-000129.md) | [3.0](/filings/0000769397-26-000061.md) | [3.2](/filings/0000769397-26-000061.md) | [3.4](/filings/0000769397-26-000061.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebt
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2024 (2023-10-31) | Q4 FY2024 (2024-01-31) | Q1 FY2025 (2024-04-30) | Q2 FY2025 (2024-07-31) | Q3 FY2025 (2024-10-31) | Q4 FY2025 (2025-01-31) | Q1 FY2026 (2025-04-30) | Q2 FY2026 (2025-07-31) | Q3 FY2026 (2025-10-31) | Q4 FY2026 (2026-01-31) | Q1 FY2027 (2026-04-30) | Q2 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [18.0 d](/filings/0000769397-24-000181.md) | [437 d](/filings/0000769397-26-000015.md) | [494](/filings/0000769397-25-000071.md) | [212 d](/filings/0000769397-25-000117.md) | [209 d](/filings/0000769397-25-000129.md) | [692 d](/filings/0000769397-26-000015.md) | [564](/filings/0000769397-26-000044.md) | [460 d](/filings/0000769397-26-000061.md) | [439 d](/filings/0000769397-25-000129.md) | [989 d](/filings/0000769397-26-000015.md) | [893](/filings/0000769397-26-000044.md) | [575 d](/filings/0000769397-26-000061.md) |
| Capital expenditure | $m | [5.0 d](/filings/0000769397-24-000181.md) | [10.0 d](/filings/0000769397-26-000015.md) | [7.0](/filings/0000769397-25-000071.md) | [9.0 d](/filings/0000769397-25-000117.md) | [10.0 d](/filings/0000769397-25-000129.md) | [14.0 d](/filings/0000769397-26-000015.md) | [8.0](/filings/0000769397-26-000044.md) | [9.0 d](/filings/0000769397-26-000061.md) | [9.0 d](/filings/0000769397-25-000129.md) | [17.0 d](/filings/0000769397-26-000015.md) | [17.0](/filings/0000769397-26-000044.md) | [14.0 d](/filings/0000769397-26-000061.md) |
| Share repurchases | $m | [114 d](/filings/0000769397-24-000181.md) | [65.0 d](/filings/0000769397-26-000015.md) | [9.0](/filings/0000769397-25-000071.md) | [111 d](/filings/0000769397-25-000117.md) | [323 d](/filings/0000769397-25-000129.md) | [409 d](/filings/0000769397-26-000015.md) | [354](/filings/0000769397-26-000044.md) | [358 d](/filings/0000769397-26-000061.md) | [359 d](/filings/0000769397-25-000129.md) | [331 d](/filings/0000769397-26-000015.md) | [448](/filings/0000769397-26-000044.md) | [453 d](/filings/0000769397-26-000061.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2023 (2022-10-31) | Q1 FY2024 (2023-04-30) | Q2 FY2024 (2023-07-31) | Q3 FY2024 (2023-10-31) | Q1 FY2025 (2024-04-30) | Q2 FY2025 (2024-07-31) | Q3 FY2025 (2024-10-31) | Q1 FY2026 (2025-04-30) | Q2 FY2026 (2025-07-31) | Q3 FY2026 (2025-10-31) | Q1 FY2027 (2026-04-30) | Q2 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [217](/filings/0000769397-23-000193.md) | [216](/filings/0000769397-24-000091.md) | [215](/filings/0000769397-24-000150.md) | [216](/filings/0000769397-24-000181.md) | [217](/filings/0000769397-25-000071.md) | [217](/filings/0000769397-25-000117.md) | [217](/filings/0000769397-25-000129.md) | [216](/filings/0000769397-26-000044.md) | [215](/filings/0000769397-26-000061.md) | [215](/filings/0000769397-25-000129.md) | [212](/filings/0000769397-26-000044.md) | [211](/filings/0000769397-26-000061.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 209,000,000 at 2026-08-21, from the cover of the [10-Q filed 2026-08-28](/filings/0000769397-26-000061.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:24 ET. No prices; not investment advice.